Tag: Financial Results

Over 1,000 Women-Led Businesses to Receive Funding Under Second Cohort of the IYBA-WE4A Programme

•  Global development leaders – EU, OACPS, BMZ, GIZ and TEF – scale up partnership to empower African women for a sustainable future. LAGOS, Nigeria, Dec. 24, 2025 /PRNewswire/ — The European Union (EU), Organisation of African, Caribbean and Pacific States (OACPS), German Federal Ministry for Economic Cooperation and Development (BMZ), Deutsche Gesellschaft für Internationale Zusammenarbeit… Continue reading Over 1,000 Women-Led Businesses to Receive Funding Under Second Cohort of the IYBA-WE4A Programme

Cango Receives Buy Rating, Upbeat on its Asset-light Mining Model and AI Potential

DALLAS, Texas, Dec. 24, 2025 /PRNewswire/ — Greenridge Capital has initiated coverage on Cango Inc. (NYSE: CANG) (“Cango” or the “Company”) with a buy rating and US$4.00 target price, noting that Cango appears to be “mispriced and overlooked by the market given its market leading Bitcoin mining status and asset-light model for entry into the high-performance… Continue reading Cango Receives Buy Rating, Upbeat on its Asset-light Mining Model and AI Potential

Is Eaton Corporation plc (ETN) Leveraging Secular Tailwinds?

TCW funds, an investment management company, released its “TCW Concentrated Large Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their rally in the third quarter, driven by continued optimism around AI investments and positive corporate earnings. Against this backdrop, the fund (I share) returned +4.11%… Continue reading Is Eaton Corporation plc (ETN) Leveraging Secular Tailwinds?

Reassessing Eaton (ETN) Valuation After Its Recent Pullback and Multiyear Rally

Eaton (ETN) has eased off its highs after a sharp multiyear climb, with the stock down about 2 % over the past month and roughly 4 % over the past year. This performance is prompting a fresh look at valuation and growth. See our latest analysis for Eaton. That recent pullback, including an 11.3% 90-day… Continue reading Reassessing Eaton (ETN) Valuation After Its Recent Pullback and Multiyear Rally

Is Eaton’s Valuation Still Justified After Its Huge Multi Year Share Price Surge?

Wondering if Eaton at around $323 a share is still a smart buy or if the big gains are already behind it? This article is going to unpack what the current price really implies about its value. The stock has dipped slightly in the short term, with returns of 2.5% over the last week but… Continue reading Is Eaton’s Valuation Still Justified After Its Huge Multi Year Share Price Surge?

I drove the world’s most powerful tractor – it’s outstanding in its field

With impressive understatement the John Deere website refers to its 9RX range of agricultural machinery as “high-horsepower tractors”. We always like it when the Christmas road test has a unique claim to fame: the biggest, the newest, the fastest or whatever it might be. And this year’s Christmas road test subject takes that ‘high horsepower’… Continue reading I drove the world’s most powerful tractor – it’s outstanding in its field

Clean Technica: Electric Door Handles — What Did Elon Know, And When Did He Know It?004302

Support CleanTechnica’s work through a Substack subscription or on Stripe. A long time ago — 2015 — in a galaxy far, far away — Silicon Valley — Elon Musk and his engineering team were working feverishly on the design for the Tesla Model 3, the first electric vehicle from the young startup aimed at mainstream… Continue reading Clean Technica: Electric Door Handles — What Did Elon Know, And When Did He Know It?004302

Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies

Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management (CBL-0201WR Phase 2). The study will evaluate CBL-514 in combination with Zepbound® (Eli Lilly) in subjects with obesity or overweight. Efficacy endpoints include changes in abdominal… Continue reading Caliway’s Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies

Record Turnout for Surfing Santas Presented by Orlando Health as Thousands of Santas Take Over Cocoa Beach

For the second year in a row Orlando Health served as the presenting sponsor for Surfing Santas. The partnership was developed in 2024 as part of Orlando Health’s expansion to the East Region, which brought critical healthcare services to the growing population of Florida’s Space Coast. “I am so proud of what Surfing Santas has become.… Continue reading Record Turnout for Surfing Santas Presented by Orlando Health as Thousands of Santas Take Over Cocoa Beach